Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...
Conditions: Depression; Quality of Life Interventions: Behavioral: Trust-building Self-management Together; Behavioral: Depression Management Sponsors: Case Western Reserve University; National Institute on Minority Health and Health Disparities (NIMHD) Recruiting
Conditions: Suicide, Attempted; Suicidal Ideation; Suicidal Intention; Suicide Interventions: Other: Clinical assessments and blood samples; follow-up for 12 mos; Other: Clinical assessments and blood samples; no 12mo follow-up Sponsors: The Cleveland Clinic; Case Western Reserve University; Van Andel Research Institute; National Institute of Mental Health (NIMH) Recruiting
Condition: Adolescent and Young Adult Cancers Interventions: Behavioral: CyberCycling; Behavioral: Stretching; Behavioral: Resistance Bands Sponsor: Case Comprehensive Cancer Center Recruiting
Conditions: Spinal Cord Injuries; Tetraplegia; Quadriplegia Intervention: Device: Using the Neuroport cortical recording array to determine the desired grasp pattern for a functional electrical stimulation (FES) system Sponsors: VA Office of Research and Development; Case Western Reserve University Recruiting
Conditions: Basal Cell Carcinoma; Basal Cell Nevus Syndrome Interventions: Dietary Supplement: Vitamin D3 prior to first visit; Dietary Supplement: Vitamin D3 prior to second visit; Radiation: Photodynamic therapy; Dietary Supplement: Maintenance Vitamin D3 Sponsors: Case Comprehensive Cancer Center; National Cancer Institute (NCI) Recruiting
Condition: Alcohol Use Interventions: Behavioral: Smartphone brief intervention (SP-BI); Other: Enhanced Usual Care (EUC) Sponsors: Joseph Calabrese, MD; Case Western Reserve University; University of Michigan; University of Toledo Health Science Campus Recruiting
Condition: Autism Spectrum Disorder Interventions: Behavioral: MABA; Behavioral: EIBI Sponsors: University of Rochester; The Cleveland Clinic; May Institute; Nationwide Children's Hospital; Vanderbilt University Medical Center; University of Michigan; University of Virginia Recruiting
Conditions: FSGS; MCD; Focal Segmental Glomerulosclerosis; Minimal Change Disease Intervention: Drug: adalimumab Sponsors: University of Michigan; New York University Recruiting
Condition: To Determine the Incidence and Type of Debris Capture in SENTINEL Devices Deployed During TAVI in Patients at Low Surgical Risk Intervention: Device: Sentinel Device Sponsors: CVPath Institute Inc.; Boston Scientific Corporation Recruiting
Conditions: Medulloblastoma; Central Nervous System Embryonal Tumors Interventions: Drug: Induction; Drug: Single Cycle Intensive Chemotherapy; Drug: Tandem 3 Cycle Intensive Chemotherapy Sponsors: Nationwide Children's Hospital; Children's Hospital Los Angeles Recruiting
Conditions: Down Syndrome; Sleep Disordered Breathing Intervention: Procedure: Adenotonsillectomy Sponsors: Brigham and Women's Hospital; Children's Hospital of Philadelphia; University Hospitals Cleveland Medical Center; Children's Hospital Medical Center, Cincinnati; University of Michigan; University of Texas Southwestern Medical Center; University of Rochester; Children's Hospital of The King's Daughters Recruiting
Conditions: Dexmedetomidine; Mechanical Ventilation Complication; Critically Ill Interventions: Drug: Fentanyl; Drug: Dexmedetomidine Sponsors: Duke University; National Institutes of Health (NIH); Johns Hopkins University; Intermountain Health Care, Inc.; Vanderbilt University Medical Center Recruiting
Condition: Sleep-Disordered Breathing Interventions: Procedure: Early Adenotonsillectomy (eAT); Behavioral: Watchful Waiting with Supportive Care (WWSC) Sponsors: Brigham and Women's Hospital; Children's Hospital of Philadelphia; University Hospitals Cleveland Medical Center; Children's Hospital Medical Center, Cincinnati; University of Michigan; University of Texas Southwestern Medical Center; University of Rochester; Children's Hospital of The King's Daughters; Boston Children’s Hospital Recruiting
Condition: Early-Onset Scoliosis Deformity of Spine Intervention: Device: MAGEC® Spinal Bracing And Distraction System Sponsors: Children's Spine Foundation; Columbia University Recruiting
Condition: Apnea of Prematurity Interventions: Drug: Caffeine Citrate; Drug: Placebo Sponsors: NICHD Neonatal Research Network; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Condition: Anterior Cruciate Ligament Reconstruction Interventions: Other: Non-operative treatment group will undergo standardized treatment which will include rehabilitation, bracing and certain activity restrictions; Procedure: Surgical technique: Transphyseal reconstruction; Procedure: Surgical technique: Partial transphyseal reconstruction; Procedure: Surgical technique: Physeal sparing reconstruction by the Anderson method; Procedure: Surgical technique: Physeal sparing reconstruction by the Micheli/Kocher method Sponsors: Boston Children’s Hospital; Children's Hospital of Philadelphia; Children's Hospital Medical Center, Cincinnati; Rady Children's Hospital, San Diego; Washington University School of Medicine; Children's Healthcare of Atlanta; The Cleveland Clinic; Tennessee Orthopedic Alliance; Hospital for Special Surgery, New York; Stanford University Recruiting
Conditions: Infant, Newborn; Hypoxia, Brain; Hypoxia-Ischemia, Brain; Encephalopathy, Hypoxic-Ischemic; Hypoxic-Ischemic Encephalopathy; Ischemic-Hypoxic Encephalopathy Interventions: Device: Hypothermia; Procedure: Normothermic Control Sponsors: NICHD Neonatal Research Network; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Conditions: Infant, Newborn; Infant, Low Birth Weight; Infant, Small for Gestational Age; Infant, Premature Intervention: Sponsors: NICHD Neonatal Research Network; National Center for Research Resources (NCRR); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Conditions: Minimal Change Disease (MCD); Membranous Nephropathy; Glomerulosclerosis, Focal Segmental Intervention: Procedure: Kidney Biopsy Sponsors: University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The NephCure Foundation Recruiting
Condition: Hypertension Interventions: Drug: Anti-hypertensive therapy; Other: No anti-hypertensive therapy (unless BP is severe) Sponsors: University of Alabama at Birmingham; Columbia University; Drexel University College of Medicine; Rutgers, The State University of New Jersey; Lehigh Valley Hospital; Saint Peters University Hospital; Christiana Care Health Services; Washington University School of Medicine; Duke University; University of Texas Southwestern Medical Center; The University of Texas Health Science Center, Houston; Stanford University; University of Pennsylvania; The University of Texas Medical Branch, Galveston; University of Utah; Intermountain Health Care, Inc.; University of California, San Francisco; Johns Hopkins University; University of Pittsburgh; Ochsner Health System; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI); WakeMed Health and Hospitals; San Francisco General Hospital; McKay-Dee Hospital; Winthrop University Hospital; New York Hospital Queens; Latter Day Saints Hospital; Lyndon B Johnson General Hospital; Virtua Medical Group; Bayview Medical Center; Duke Regional Hospital; Utah Valley Regional Medical Center; Northwestern; Brown (WIHRI); Baylor College of Medicine; Case Western/Metro Health; Ohio State University; University of Iowa; University of California, San Diego; Indiana University; Unity Point Health-Meriter Hospital WI; Weill Medical College of Cornell University; University of Oklahoma; Medical University of South Carolina; Beaumont Hospital; University of Colorado, Denver; University of Kansas Medical Center; Denver Health and Hospital Authority; Gundersen Health System; Aurora Health Care; Oregon Health and Science University; Medical College of Wisconsin; Temple University; New Jersey Medical School; University of South Alabama; Vanderbilt University; University of Arkansas; Miami Valley Hospital; Emory University; St. Luke's Hospital and Health Network, Pennsylvania; Cleveland Clinic Fairview Hospital; University of Tennessee Health Science Center; TriHealth Inc.; Cleveland Clinic Hillcrest Hospital; Tulane University; Yale University; Arrowhead Regional Medical Center; Geisinger Clinic Recruiting
Conditions: Mitochondrial Disorders; Mitochondrial Genetic Disorders; Mitochondrial Diseases; Disorder of Mitochondrial Respiratory Chain Complexes; Deletion and Duplication of Mitochondrial DNA Intervention: Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
Conditions: Degenerative and Traumatic Pathology of the Knee; Degenerative and Traumatic Pathology of the Shoulder and Elbow; Degenerative and Traumatic Pathology of the Foot and Ankle; Degenerative and Traumatic Pathology of the Hand and Wrist; Degenerative and Traumatic Pathology of the Hip Intervention: Sponsor: Arthrex, Inc. Recruiting
Conditions: Sleep Apnea, Obstructive; Down Syndrome Intervention: Device: Inspire® Upper Airway Simulation System (Model 3028 IPG ) Sponsors: Christopher Hartnick, M.D.; Massachusetts General Hospital; University Hospitals Cleveland Medical Center; Emory University; Children's Hospital Medical Center, Cincinnati; Inspire Medical Systems, Inc.; University of Pittsburgh; Children's Hospital of The King's Daughters; University of Texas Southwestern Medical Center; Texas Children's Hospital; Oregon Health and Science University; C.S. Mott Children's Hospital; Seattle Children's Hospital; Children's Hospital of Philadelphia Recruiting
Condition: Lennox Gastaut Syndrome Interventions: Drug: ZX008 0.2 or 0.8 mg/kg/day; Drug: Matching Placebo Sponsor: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. Recruiting
Conditions: Childhood Malignant Neoplasm; Cognitive Side Effects of Cancer Therapy Interventions: Procedure: Cognitive Assessment; Other: Quality-of-Life Assessment Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Recruiting
Condition: Pediatric Crohn's Disease Interventions: Drug: Methotrexate; Other: Sugar pill (placebo) Sponsors: University of North Carolina, Chapel Hill; Patient-Centered Outcomes Research Institute; ImproveCareNow (ICN); The Leona M. and Harry B. Helmsley Charitable Trust; Children's Hospital Medical Center, Cincinnati; Grifols Diagnostics Solutions, Inc; National Institutes of Health (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Recruiting
Conditions: Surgery; Anesthesia; Children Intervention: Sponsors: The Society for Pediatric Anesthesia; Children's Hospital Medical Center, Cincinnati; Monroe Carell Jr. Children's Hospital at Vanderbilt; Seattle Children's Hospital; Boston Children’s Hospital; Emory-Children's Center; Texas Children's Hospital; Johns Hopkins University; Children's Hospital Los Angeles; Morgan Stanley Children's Hospital of New York; Children's Hospital of Philadelphia; Ann & Robert H Lurie Children's Hospital of Chicago; University of Pittsburgh; Phoenix Children's Hospital; University of Michigan; Children's National Health System; Nationwide Children's Hospital; Arkansas Children's Hospital Research Institute; Children's Hospital Colorado; St. Jude Children's Research Hospital; Cook Children's Health Care System; SSM Cardinal Glennon Children's Medical Center; The Children's Hospital at Montefiore; Children's Medical Center Dallas; Lucile Packard Children's Hospital Stanford; Alfred I. duPont Hospital for Children; Johns Hopkins All Children's Hospital; Children's Hospitals and Clinics of Minnesota; Oakland Medical Center; Children's Hospital and Medical Center, Omaha, Nebraska; Medical University of South Carolina; Akron Children's Hospital; Women & Children's Hospital of Buffalo; Dayton Children's Hospital; Riley Children's Hospital; Cleveland Clinic Children's Hospital; Penn State Hershey Children's Hospital Recruiting
Condition: Urinary Stones Interventions: Behavioral: Fluid prescription; Behavioral: Financial incentive; Behavioral: Structured Problem Solving Sponsors: Duke University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Condition: Gonorrhea Interventions: Drug: zoliflodacin; Drug: ceftriaxone; Drug: azithromycin Sponsor: Global Antibiotics Research and Development Partnership Recruiting
Conditions: Preeclampsia; Obstetric Labor Complications; Hypertension in Pregnancy Interventions: Drug: Pravastatin; Other: Placebo Sponsors: The George Washington University Biostatistics Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Heart, Lung, and Blood Institute (NHLBI) Recruiting
Condition: Cardiovascular Diseases Intervention: Device: ABIOMED, Inc. hemodynamic support devices Sponsors: Abiomed Inc.; Beth Israel Deaconess Medical Center; Yale University Recruiting
Conditions: Short Cervix; Preterm Delivery Intervention: Device: Pessary Sponsors: The George Washington University Biostatistics Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Conditions: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Non-hodgkin Lymphoma; Hodgkin Lymphoma; Acquired Aplastic Anemia; Sickle Cell Disease Intervention: Other: Donor Search Prognosis Score Sponsors: Center for International Blood and Marrow Transplant Research; National Heart, Lung, and Blood Institute (NHLBI); National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials Network; National Marrow Donor Program; Medical College of Wisconsin Recruiting
Conditions: Ann Arbor Stage I Hodgkin Lymphoma; Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma; Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma; Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma; Ann Arbor Stage IA Hodgkin Lymphoma; Ann Arbor Stage IB Hodgkin Lymphoma; Ann Arbor Stage II Hodgkin Lymphoma; Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma; Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma; Ann Arbor Stage II Nodular Sclerosis Classic Hodgkin Lymphoma; Ann Arbor Stage IIA Hodgkin Lymphoma; Ann Arbor Stage IIB Hodgkin Lymphoma; Classic Hodgkin Lymphoma; Lymphocyte-Rich Classic Hodgkin Lymphoma Interventions: Drug: Bleomycin; Drug: Brentuximab Vedotin; Drug: Dacarbazine; Drug: Doxorubicin; Biological: Nivolumab; Other: Quality-of-Life Assessment; Drug: Vinblastine Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Recruiting
Condition: Idiopathic Dilated Cardiomyopathy Intervention: Behavioral: Family Heart Talk Booklet Sponsors: Ray Hershberger; National Heart, Lung, and Blood Institute (NHLBI); National Human Genome Research Institute (NHGRI) Recruiting
Conditions: Eosinophilic Granulomatosis With Polyangiitis; Churg-Strauss Syndrome Intervention: Sponsors: University of Pennsylvania; Office of Rare Diseases (ORD); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Rare Diseases Clinical Research Network Recruiting
Condition: Short Cervical Length Interventions: Drug: Vaginal progesterone; Drug: Placebo; Device: Arabin Pessary Sponsors: The George Washington University Biostatistics Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Conditions: Amyotrophic Lateral Sclerosis; Frontotemporal Dementia; Primary Lateral Sclerosis; Hereditary Spastic Paraplegia; Progressive Muscular Atrophy; Multisystem Proteinopathy Intervention: Sponsors: University of Miami; National Institute of Neurological Disorders and Stroke (NINDS); National Center for Advancing Translational Science (NCATS); St. Jude Children's Research Hospital; ALS Association Recruiting
Condition: Early Breast Cancer Intervention: Radiation: Boost to the tumour bed Sponsors: University College, London; National Institute for Health Research, United Kingdom Recruiting
Condition: Chronic Hypoparathyroidism Intervention: Drug: Combination product (Natpara) and drug or supplements [Disease and drug registry] Sponsor: Shire Recruiting
Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss); Giant Cell Arteritis; Granulomatosis With Polyangiitis (Wegener's); Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu's Arteritis Intervention: Sponsors: University of Pennsylvania; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Office of Rare Diseases (ORD); Rare Diseases Clinical Research Network Recruiting
Conditions: Severe Combined Immunodeficiency (SCID); Leaky SCID; Omenn Syndrome; Reticular Dysgenesis; ADA SCID; XSCID Intervention: Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Primary Immune Deficiency Treatment Consortium (PIDTC); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS) Recruiting